Clinical Trials
11 trialsNCT04172532 2026-05-22
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
National Cancer Institute (NCI)
Phase 1/2 Recruiting
NCT04068194 2026-05-13
Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies
National Cancer Institute (NCI)
Phase 1/2 Active not recruiting
NCT04454528 2026-03-10
BreastVAX
Abramson Cancer Center at Penn Medicine
Phase 1/2 Active not recruiting
NCT04683653 2025-12-29
Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer
University of Chicago
Phase 1/2 Recruiting
NCT01985087 2024-10-31
A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70
University of Louisville
Phase 1/2 Active not recruiting
NCT04636008 2024-08-06
Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer
West China Hospital
Phase 1/2 Recruiting
NCT05451173 2023-10-03
Combining ICI With SBRT or HypoFrx-RT for ES NSCLC
Xuanwu Hospital, Beijing
Phase 1/2 Unknown
NCT05210270 2023-01-31
HYACINCT
University of Santo Tomas Hospital, Philippines
Phase 1/2 Not yet recruiting
NCT01505075 2020-11-24
pHART8
Sunnybrook Health Sciences Centre
Phase 1/2 Unknown
NCT01146340 2019-10-04
PHART6
Sunnybrook Health Sciences Centre
Phase 1/2 Completed
NCT00129025 2011-10-10
Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer
AHS Cancer Control Alberta
Phase 1/2 Completed